Third world is swamped with fake TB drugs, study finds

Africa, India and other developing countries are awash in fake or sub-standard drugs for tuberculosis, fuelling the rise of treatment-resistant strains of TB, according to a survey published on Tuesday.

Investigators in the United States asked local people in 19 cities in 17 countries to purchase isoniazid and rifampicin, the frontline antibiotics for TB, from a private-sector pharmacy.

The samples were then examined by chromatography, a technique that detects , for their active ingredient.

They were also tested for disintegration, to see if they properly broke up in water at body temperature within 30 minutes.

Out of 713 samples, 9.1 percent failed these basic quality control tests, according to the probe, published in the .

Around half of the failed samples had zero active ingredients, "making them likely to contribute to ," it said.

Resistance to develops when treatment fails to kill the bacteria that causes it—either because the patient fails to follow their prescribed dosages or, as in this case, the doesn't work.

It can also be contracted through rare forms of the disease that are directly transmissible from person to person.

Dud drugs were manufactured by legitimate companies and criminal fraudsters, said the report.

The pharmacies where the drugs were purchased were in Luanda, Angola; Sao Paulo, Brazil; Beijing, China; Lubumbashi, ; Cairo, Egypt; Addis Ababa, Ethiopia; Accra, Ghana; Chennai, Delhi and Kolkata, India; Nairobi, Kenya; Lagos, Nigeria; Moscow, Russia; Kigali, Rwanda; Dar-es-Salaam, Tanzania; Bangkok, Thailand; Istanbul, Turkey; Kampala, Uganda; and Lusaka, Zambia.

The failure rate was 16.6 percent in Africa, 10.1 percent in India and 3.9 percent in Brazil, China, Thailand, Turkey and Russia.

Nearly nine million people around the world have TB, including more than 400,000 with a multidrug-resistant form of the disease, according to estimates for 2011 compiled by the World Health Organisation (WHO).

TB is one of the world's deadliest diseases. It is spread from person to person through the air and usually affects the lungs, but it can also affect other parts of the body such as the brain and kidneys.

add to favorites email to friend print save as pdf

Related Stories

WHO: Money, drugs needed to rein in new TB strains

Mar 23, 2009

(AP) -- More money and better science are urgently needed to rein in new strains of tuberculosis that are tough or nearly impossible to treat, the WHO announced Monday in China, where the disease has long been a leading ...

Drug-resistant TB blamed on Indian treatment flaws

Mar 23, 2012

(AP) -- India's inadequate government-run tuberculosis treatment programs and a lack of regulation of the sale of drugs that fight it are responsible for the spiraling number of drug-resistant cases that are difficult to ...

Indian experts probing 'untreatable' TB cases

Jan 17, 2012

The Indian government on Tuesday dispatched a team of medical experts to the financial capital, Mumbai, to assess reports of a handful of cases of apparently untreatable tuberculosis.

Recommended for you

Determine patient preferences by means of conjoint analysis

17 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments